Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hepatic
pyruvate kinase phosphatase
activity has been assayed in native conditions, in Sephadex G-25 filtered extracts of rat hepatocytes, by measuring the reactivation rate of glucagon-inactivated pyruvate kinase-L. The ionic requirements for this reaction, as well as the possible regulatory role of some pyruvate kinase ligands, have been investigated. Pyruvate kinase phosphatase activity was dependent on divalent cations (Mg2+, Mn2+ or Co2+). Mg2+ ions highly enhanced the reactivation rate of pyruvate kinase, while the presence of 100 mM KF inhibited this process. Physiological concentrations of phosphoenolpyruvate or fructose 1,6-bisphosphate inhibited
pyruvate kinase phosphatase
activity. These inhibitory effects were partially antagonized by the presence of L-alanine. Our results suggest that ligands of pyruvate kinase could play a role in the control of
pyruvate kinase phosphatase
activity(ies), possibly by modifying the conformational state of the substrate protein.
Mol
Cell Biochem 1983
PMID:Modulation of pyruvate kinase phosphatase activity in hepatocyte extracts by pyruvate kinase-L ligands. 630 88